Department of Medicine, Section of Gastroenterology, Southern Arizona VA Health Care System and University of Arizona Health Sciences Center, Tucson, Arizona 85723-0001, USA.
Gastrointest Endosc. 2010 Jan;71(1):28-34. doi: 10.1016/j.gie.2009.08.024.
Failure of proton pump inhibitor (PPI) treatment in patients with heartburn is very common. Because endoscopy is easily accessible, it is commonly used as the first evaluative tool in these patients.
To compare GERD-related endoscopic and histologic findings in patients with heartburn in whom once-daily PPI therapy failed versus those not receiving antireflux treatment.
Cross-sectional study.
A Veterans Affairs hospital.
Heartburn patients from the GI outpatient clinic.
Recording of endoscopic results.
Endoscopic findings and association between PPI treatment failure and esophageal mucosal injury by using logistic regression models.
A total of 105 subjects (mean age 54.7 +/- 15.7 years; 71 men, 34 women) were enrolled in the PPI treatment failure group and 91 (mean age 53.4 +/- 15.8 years; 68 men, 23 women) were enrolled in the no-treatment group (P = not significant). Anatomic findings during upper endoscopy were significantly more common in the no-treatment group compared with the PPI treatment failure group (55.2% vs 40.7%, respectively; P = .04). GERD-related findings were significantly more common in the no-treatment group compared with the PPI treatment failure group (erosive esophagitis: 30.8% vs 6.7%, respectively; P < .05). Eosinophilic esophagitis was found in only 0.9% of PPI treatment failure patients. PPI treatment failure was associated with a significantly decreased odds ratio of erosive esophagitis compared with no treatment, adjusted for age, sex, and body mass index (adjusted odds ratio 0.11; 95% CI, 0.04-0.30).
Heartburn patients in whom once-daily PPI treatment failed demonstrated a paucity of GERD-related findings compared with those receiving no treatment. Eosinophilic esophagitis was uncommon in PPI therapy failure patients. Upper endoscopy seems to have a very low diagnostic yield in this patient population.
烧心患者质子泵抑制剂(PPI)治疗失败很常见。由于内镜检查容易进行,因此通常将其作为这些患者的首选评估工具。
比较烧心且 PPI 治疗失败患者与未接受抗反流治疗患者的胃食管反流病(GERD)相关内镜和组织学发现。
横断面研究。
退伍军人事务医院。
GI 门诊诊所的烧心患者。
记录内镜结果。
使用逻辑回归模型评估内镜发现和 PPI 治疗失败与食管黏膜损伤之间的相关性。
共有 105 例患者(平均年龄 54.7±15.7 岁;71 例男性,34 例女性)被纳入 PPI 治疗失败组,91 例患者(平均年龄 53.4±15.8 岁;68 例男性,23 例女性)被纳入未治疗组(P=无统计学意义)。与 PPI 治疗失败组相比,未治疗组的上消化道内镜检查时解剖学发现更常见(分别为 55.2%和 40.7%,P=0.04)。与 PPI 治疗失败组相比,未治疗组的 GERD 相关发现更常见(糜烂性食管炎:分别为 30.8%和 6.7%,P<0.05)。PPI 治疗失败患者中仅发现 0.9%的嗜酸性食管炎。与未治疗相比,PPI 治疗失败与糜烂性食管炎的比值比显著降低,调整年龄、性别和体重指数后(调整比值比 0.11;95%CI,0.04-0.30)。
与未接受治疗的患者相比,每日一次 PPI 治疗失败的烧心患者的 GERD 相关发现较少。PPI 治疗失败患者中嗜酸性食管炎少见。在上消化道内镜检查中,该患者人群的诊断率非常低。